Single daily administration of spirapril in the treatment of essential hypertension. A multicentre double-blind comparison of 1, 6, 12 and 24 mg of spirapril once daily.

Abstract

A total of 171 male and female patients with mild-to-moderate hypertension [diastolic blood pressure (DBP) 100-115 mmHg] entered this randomized, double-blind, multicentre study. A 3-week placebo run-in period was followed by a 5-week active-treatment period during which patients received either 1, 6, 12 or 24 mg of spirpril once daily. Predose sitting… (More)

Topics

Cite this paper

@article{Hayduk1994SingleDA, title={Single daily administration of spirapril in the treatment of essential hypertension. A multicentre double-blind comparison of 1, 6, 12 and 24 mg of spirapril once daily.}, author={K. Hayduk and Florian Schardt and Bartosz Michał Sierakowski and Gilbert Weidinger and Dieter Welzel}, journal={Blood pressure. Supplement}, year={1994}, volume={2}, pages={41-6} }